• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病的四大主要治疗关键:一篇小型综述。

Four main therapeutic keys for Parkinson's disease: A mini review.

作者信息

Hernandez-Baltazar Daniel, Nadella Rasajna, Mireya Zavala-Flores Laura, Rosas-Jarquin Christian de Jesús, Rovirosa-Hernandez María de Jesús, Villanueva-Olivo Arnulfo

机构信息

CONACYT-Instituto de Neuroetologia, Universidad Veracruzana, Xalapa, Veracruz, Mexico.

IIIT Srikakulam, Rajiv Gandhi University of Knowledge Technologies (RGUKT); International collaboration ID:1840; India.

出版信息

Iran J Basic Med Sci. 2019 Jul;22(7):716-721. doi: 10.22038/ijbms.2019.33659.8025.

DOI:10.22038/ijbms.2019.33659.8025
PMID:32373291
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7196346/
Abstract

OBJECTIVES

Parkinson's disease (PD) is characterized by motor and cognitive dysfunctions. The progressive degeneration of dopamine-producing neurons that are present in the (SNpc) has been the main focus of study and PD therapies since ages.

MATERIALS AND METHODS

In this manuscript, a systematic revision of experimental and clinical evidence of PD-associated cell process was conducted.

RESULTS

Classically, the damage in the dopaminergic neuronal circuits of SNpc is favored by reactive oxidative/nitrosative stress, leading to cell death. Interestingly, the therapy for PD has only focused on avoiding the symptom progression but not in finding a complete reversion of the disease. Recent evidence suggests that the renin-angiotensin system imbalance and neuroinflammation are the main keys in the progression of experimental PD.

CONCLUSION

The progression of neurodegeneration in SNpc is due to the complex interaction of multiple processes. In this review, we analyzed the main contribution of four cellular processes and discussed in the perspective of novel experimental approaches.

摘要

目的

帕金森病(PD)的特征在于运动和认知功能障碍。自多年来,存在于黑质致密部(SNpc)的多巴胺能神经元的进行性退化一直是研究和PD治疗的主要焦点。

材料与方法

在本手稿中,对与PD相关的细胞过程的实验和临床证据进行了系统修订。

结果

传统上,SNpc多巴胺能神经元回路的损伤受反应性氧化/亚硝化应激的影响,导致细胞死亡。有趣的是,PD的治疗仅专注于避免症状进展,而不是寻找疾病的完全逆转。最近的证据表明,肾素-血管紧张素系统失衡和神经炎症是实验性PD进展的主要关键。

结论

SNpc中神经退行性变的进展是由于多种过程的复杂相互作用。在本综述中,我们分析了四个细胞过程的主要贡献,并从新的实验方法角度进行了讨论。

相似文献

1
Four main therapeutic keys for Parkinson's disease: A mini review.帕金森病的四大主要治疗关键:一篇小型综述。
Iran J Basic Med Sci. 2019 Jul;22(7):716-721. doi: 10.22038/ijbms.2019.33659.8025.
2
Trib3 Is Elevated in Parkinson's Disease and Mediates Death in Parkinson's Disease Models.TRIB3在帕金森病中升高并介导帕金森病模型中的细胞死亡。
J Neurosci. 2015 Jul 29;35(30):10731-49. doi: 10.1523/JNEUROSCI.0614-15.2015.
3
Glutaredoxin 1 Downregulation in the Substantia Nigra Leads to Dopaminergic Degeneration in Mice.黑质中谷氧还蛋白1的下调导致小鼠多巴胺能神经元变性。
Mov Disord. 2020 Oct;35(10):1843-1853. doi: 10.1002/mds.28190. Epub 2020 Jul 3.
4
Direct intranigral injection of dopaminochrome causes degeneration of dopamine neurons.直接向黑质内注射多巴色素会导致多巴胺能神经元变性。
Neurosci Lett. 2016 Jan 26;612:178-184. doi: 10.1016/j.neulet.2015.12.028. Epub 2015 Dec 15.
5
Dopaminergic D2 receptor is a key player in the substantia nigra pars compacta neuronal activation mediated by REM sleep deprivation.多巴胺 D2 受体是 REM 睡眠剥夺介导的黑质致密部神经元激活的关键因素。
Neuropharmacology. 2014 Jan;76 Pt A:118-26. doi: 10.1016/j.neuropharm.2013.08.024. Epub 2013 Sep 4.
6
Characterization of substantia nigra neurogenesis in homeostasis and dopaminergic degeneration: beneficial effects of the microneurotrophin BNN-20.黑质神经发生的特征:在自稳态和多巴胺能变性中的作用:微量神经生长因子 BNN-20 的有益作用。
Stem Cell Res Ther. 2021 Jun 10;12(1):335. doi: 10.1186/s13287-021-02398-3.
7
A Pitx3-deficient developmental mouse model for fine motor, olfactory, and gastrointestinal symptoms of Parkinson's disease.一个 Pitx3 缺陷的发育性小鼠模型,用于模拟帕金森病的精细运动、嗅觉和胃肠道症状。
Neurobiol Dis. 2022 Aug;170:105777. doi: 10.1016/j.nbd.2022.105777. Epub 2022 May 27.
8
Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.帕金森病1-甲基-4-苯基-1,2,3,6-四氢吡啶/丙磺舒渐进性神经退行性小鼠模型黑质致密部神经元凋亡的早期迹象。
Neuroscience. 2006 Jun 19;140(1):67-76. doi: 10.1016/j.neuroscience.2006.02.007. Epub 2006 Mar 14.
9
Early activation of Egr-1 promotes neuroinflammation and dopaminergic neurodegeneration in an experimental model of Parkinson's disease.早期激活 Egr-1 可促进帕金森病实验模型中的神经炎症和多巴胺能神经退行性变。
Exp Neurol. 2018 Apr;302:145-154. doi: 10.1016/j.expneurol.2018.01.009. Epub 2018 Jan 11.
10
Uncovering Novel Therapeutic Targets for Parkinson's Disease.揭示帕金森病的新治疗靶点。
ACS Chem Neurosci. 2023 Jun 7;14(11):1935-1949. doi: 10.1021/acschemneuro.3c00084. Epub 2023 May 25.

引用本文的文献

1
Isoalantolactone (IAL) Regulates Neuro-Inflammation and Neuronal Apoptosis to Curb Pathology of Parkinson's Disease.异土木香内酯(IAL)通过调控神经炎症和神经元凋亡抑制帕金森病的病理进程。
Cells. 2022 Sep 19;11(18):2927. doi: 10.3390/cells11182927.
2
Effects of Cannabidiol on Parkinson's Disease in a Transgenic Mouse Model by Gut-Brain Metabolic Analysis.通过肠脑代谢分析研究大麻二酚对转基因小鼠模型帕金森病的影响。
Evid Based Complement Alternat Med. 2022 Mar 22;2022:1525113. doi: 10.1155/2022/1525113. eCollection 2022.
3
Cannabidiol as a Therapeutic Target: Evidence of its Neuroprotective and Neuromodulatory Function in Parkinson's Disease.

本文引用的文献

1
Therapeutic strategies for Parkinson disease: beyond dopaminergic drugs.帕金森病的治疗策略:超越多巴胺能药物
Nat Rev Drug Discov. 2018 Nov;17(11):804-822. doi: 10.1038/nrd.2018.136. Epub 2018 Sep 28.
2
Targeting GSK3 signaling as a potential therapy of neurodegenerative diseases and aging.靶向 GSK3 信号作为神经退行性疾病和衰老的潜在治疗方法。
Expert Opin Ther Targets. 2018 Oct;22(10):833-848. doi: 10.1080/14728222.2018.1526925. Epub 2018 Sep 26.
3
New insights into the complex role of mitochondria in Parkinson's disease.
大麻二酚作为一种治疗靶点:其在帕金森病中神经保护和神经调节功能的证据
Front Pharmacol. 2020 Dec 15;11:595635. doi: 10.3389/fphar.2020.595635. eCollection 2020.
对线粒体在帕金森病中复杂作用的新认识。
Prog Neurobiol. 2019 Jun;177:73-93. doi: 10.1016/j.pneurobio.2018.09.003. Epub 2018 Sep 13.
4
Role of protein kinase Cδ in dopaminergic neurotoxic events.蛋白激酶 Cδ在多巴胺能神经毒性事件中的作用。
Food Chem Toxicol. 2018 Nov;121:254-261. doi: 10.1016/j.fct.2018.09.005. Epub 2018 Sep 6.
5
Chaperone-mediated autophagy as a therapeutic target for Parkinson disease.伴侣蛋白介导的自噬作为帕金森病的治疗靶点。
Expert Opin Ther Targets. 2018 Oct;22(10):823-832. doi: 10.1080/14728222.2018.1517156. Epub 2018 Sep 10.
6
Neuroprotection by immunomodulatory agents in animal models of Parkinson's disease.免疫调节药物在帕金森病动物模型中的神经保护作用。
Neural Regen Res. 2018 Sep;13(9):1493-1506. doi: 10.4103/1673-5374.237108.
7
Impaired Mitophagy and Protein Acetylation Levels in Fibroblasts from Parkinson's Disease Patients.帕金森病患者成纤维细胞中的线粒体自噬受损和蛋白质乙酰化水平降低。
Mol Neurobiol. 2019 Apr;56(4):2466-2481. doi: 10.1007/s12035-018-1206-6. Epub 2018 Jul 21.
8
On Cell Loss and Selective Vulnerability of Neuronal Populations in Parkinson's Disease.帕金森病中神经元群体的细胞丢失与选择性易损性
Front Neurol. 2018 Jun 19;9:455. doi: 10.3389/fneur.2018.00455. eCollection 2018.
9
Acute Neuroinflammatory Response in the Substantia Nigra Pars Compacta of Rats after a Local Injection of Lipopolysaccharide.脂多糖局部注射后大鼠黑质致密部的急性神经炎症反应。
J Immunol Res. 2018 May 8;2018:1838921. doi: 10.1155/2018/1838921. eCollection 2018.
10
Anti-Parkinson Potential of Silymarin: Mechanistic Insight and Therapeutic Standing.水飞蓟素的抗帕金森病潜力:作用机制洞察与治疗地位
Front Pharmacol. 2018 Apr 27;9:422. doi: 10.3389/fphar.2018.00422. eCollection 2018.